Literature DB >> 7848792

A survey of neurological disability at a district general hospital.

E D Playford1, P Crawford, P S Monro.   

Abstract

Neurological disease accounts for 20% of all admissions to medical wards, but the number of inpatients with neurological disability is unknown. The notes of all adult inpatient in a district general hospital were reviewed to identify all those with a neurological disorder. Over 40% of inpatients on medical wards and 4% on surgical wards had a neurological disorder. Stroke was the most common neurological diagnosis, accounting for 36% of neurological disorders and 22% of all patients on medical wards. Other neurological diagnoses included dementias 10%, degenerative disorders 10%, epilepsy 7%, demyelination 4%, and head injuries 3%. Neurological patients have long inpatient stays (mean 80 days), and often remain in hospital awaiting changes in accommodation. Seven patients under 65 years stayed more than 6 months awaiting long-term care. Neurological disorders contribute significantly to the inpatient workload. Identifying those requiring rehabilitation and concentrating them on one ward could improve the quality and efficiency of their care.

Entities:  

Mesh:

Year:  1994        PMID: 7848792

Source DB:  PubMed          Journal:  Br J Clin Pract        ISSN: 0007-0947


  3 in total

1.  Provision of 24 hour acute neurology care by neurologists: manpower requirements in the UK.

Authors:  C Carroll; J Zajicek
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

2.  Pattern of neurological disease seen among patients admitted in tertiary care hospital.

Authors:  Rajib Nayan Chowdhury; A T M Hasibul Hasan; Yusuf Ur Rahman; Shafikul Islam Khan; Ahmed Riyad Hussain; Shamim Ahsan
Journal:  BMC Res Notes       Date:  2014-03-31

3.  Appropriateness of acute admissions and last in-patient day for patients with long term neurological conditions.

Authors:  Christina L Hammond; Margaret F Phillips; Lorraine L Pinnington; Benedict J Pearson; Apostolos Fakis
Journal:  BMC Health Serv Res       Date:  2009-02-27       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.